WestPark Capital Initiates Coverage On Veru with Buy Rating, Announces Price Target of $28
10/6/2026
Impact: 75
Healthcare
WestPark Capital analyst Ed Arce has initiated coverage on Veru (NASDAQ: VERU) with a Buy rating. The firm has set a price target of $28 for the stock.
AI summary, not financial advice
Share: